Education: PhD, Public Health, New York University, 2021; MA, Global Health, Arizona State University, 2016; BA, Global Health, Arizona State University, 2015; BS, Psychology, Arizona State University, 2015
Drew Blasco, PhD, MA
Drew Blasco is a Postdoctoral Research Fellow at the University of Michigan in the U-M ELSI Research Training Program. Dr. Blasco is interested in the implications of labeling individuals as “at-risk” for future illness development. Specifically, her work examines the conceptions of genetic risk for the development of psychosis and the implications for future genetic testing for psychosis leading to the identification of individuals as clinically high-risk for psychosis. While at U-M, Drew extended her work to genetic testing for Alzheimer’s disease (AD) and other neuropsychiatric conditions experienced in late life. Currently, she is studying the use of genetic testing for AD related to newly approved AD treatments.
Dr. Blasco earned her PhD from New York University in Public Health in 2021, as well as a Master of Arts in Global Health from Arizona State University in 2016. Before this, she earned two Bachelor’s degrees from Arizona State University in Global Health and Psychology in 2015.